Division of Hematology and Clinical Immunology
261 – 270 of 779
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Direct evidence for a polygenic etiology in familial multiple myeloma
- Contribution to journal › Article
-
Mark
Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations
- Contribution to journal › Article
-
Mark
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register
- Contribution to journal › Article
-
Mark
The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo
- Contribution to journal › Article
-
Mark
Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies
- Contribution to journal › Article
-
Mark
Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1
- Contribution to journal › Article
-
Mark
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors : a multicenter IMWG study
- Contribution to journal › Article
-
Mark
Working toward precision medicine : Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges
- Contribution to journal › Article
-
Mark
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone : A pooled analysis
- Contribution to journal › Article
-
Mark
Low levels of interleukin-10 in patients with transfusion-related acute lung injury
- Contribution to journal › Letter
